Skip to main content
OpenTrials

Clinical trial condition

Migraine Disorders

Explore clinical trials studying Migraine Disorders. Study availability and eligibility vary by location and protocol.

1,131 public trials 139 recruiting studies
Refine in advanced search Browse all conditions

Migraine Disorders trial results

Completed

Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine

NCT02638103

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • Teva Investigational Site 13628 Birmingham, Alabama, United States
  • Teva Investigational Site 13577 Birmingham, Alabama, United States
  • Teva Investigational Site 13606 Phoenix, Arizona, United States
  • Teva Investigational Site 13579 Phoenix, Arizona, United States
View all 139 locations
View Trial Details
Completed

Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine

NCT02629861

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • Teva Investigational Site 13628 Birmingham, Alabama, United States
  • Teva Investigational Site 13577 Birmingham, Alabama, United States
  • Teva Investigational Site 13577 Birmingham, Alabama, United States
  • Teva Investigational Site 13628 Birmingham, Alabama, United States
View all 275 locations
View Trial Details
Completed

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine

NCT02621931

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • Teva Investigational Site 13628 Birmingham, Alabama, United States
  • Teva Investigational Site 13577 Birmingham, Alabama, United States
  • Teva Investigational Site 13577 Birmingham, Alabama, United States
  • Teva Investigational Site 13628 Birmingham, Alabama, United States
View all 273 locations
View Trial Details
Completed

Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine

NCT03828539

Conditions
Brain Diseases, Central Nervous System Diseases, Headache, +9 more
Locations
  • Novartis Investigative Site Stuttgart, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Marburg Wehrda, Germany
  • Novartis Investigative Site Hanover, Lower Saxony, Germany
  • Novartis Investigative Site Aachen, North Rhine-Westphalia, Germany
View all 79 locations
View Trial Details
Completed

Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients

NCT03333109

Conditions
Brain Diseases, Central Nervous System Diseases, Episodic Migraine, +9 more
Locations
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site Buenos Aires, Argentina
View all 81 locations
View Trial Details

Related conditions